Lexaria’s DehydraTECH™ technology is covered by a robust suite of issued and pending patents in over 50 countries around the world. Lexaria`s patent suite commenced with two initial 2014 US provisional patent applications. Since then, Lexaria has broadened the patent suite considerably.
In addition to US patent filings, Lexaria has also pursued international patent protection through filings under the Patent Cooperation Treaty, followed by national filings in 40+ jurisdictions that are considered to have the highest commercial potential. Lexaria has 27 patents granted for its DehydraTECH technology in the US, Australia and the European Union, Japan, Mexico and India with expectations of additional patents to be granted, and roughly 50 additional patents pending. Links to our US and Australian patents are provided for your convenience, below.